Anti-tumor effects of interleukin 2 against renal cell carcinoma. In vitro study and clinical application.
Marumo
K
K
Department of Urology, School of Medicine, Keio University, Tokyo, Japan.
Tazaki
H
H
D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D003601:Cytotoxicity Tests, Immunologic; D004341:Drug Evaluation; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D007694:Killer Cells, Natural / Q000187:drug effects; D011994:Recombinant Proteins; D014407:Tumor Cells, Cultured / Q000187:drug effects
D007155:Immunologic Factors; D007376:Interleukin-2; D011994:Recombinant Proteins; D007371:Interferon-gamma